Rahul Banerjee, Assistant Professor at the Fred Hutchinson Cancer Center and at the University of Washington, shared a post on X:
“Brilliantly written MajesTEC-3 editorial by Rakesh Popat – going after CAR-T’s tail indeed!
In his commentary:
- Dara may still have role in CD38-refractory MM after washout
- Give IVIG sooner, not later
- Time-limited bsAb trials needed
- CAR-T has a real competitor!”
Title: Biting the Tail of CAR-T for Relapsed Multiple Myeloma
Author: Rakesh Popat
Read the Full Article.
Other articles featuring Rahul Banerjee on OncoDaily.